Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The platelet dense granule secretion machinery is a specialized multi-protein complex that facilitates the exocytosis of dense granules (delta-granules), which store critical mediators such as serotonin, ADP, and calcium. The core of this machinery is the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex, primarily composed of the vesicle-SNARE VAMP-8 and the target-SNAREs Syntaxin-11 and SNAP-23 (Flaumenhaft, 2003; Ren et al., 2007). Regulatory proteins, including Munc13-4 and Rab27, are essential for the docking and priming of these granules at the plasma membrane or the open canalicular system (Shirakawa et al., 2004). Upon platelet activation by agonists like thrombin or collagen, this machinery triggers the rapid release of serotonin, which acts as a paracrine signal to amplify platelet recruitment and induce local vasoconstriction (Heijnen & van der Sluijs, 2015). Dysfunction of this machinery leads to bleeding disorders such as Hermansky-Pudlak syndrome, while overactivity contributes to pathological thrombosis. While current antiplatelet drugs like aspirin indirectly reduce secretion by blocking upstream signaling, novel therapeutic strategies are exploring the direct targeting of SNARE proteins to more precisely control platelet reactivity (Ye et al., 2012).
Inhibition of agonist-induced signaling pathways (e.g., COX-1 or P2Y12 inhibition) that trigger granule release, or direct interference with SNARE-mediated membrane fusion using peptide mimetics.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet dense granule secretion machinery.